Clinical Trial Update: Reduction or Discontinuation of TNF-α Inhibitor in Non-infectious Uveitis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update exploring reduction or discontinuation of a TNF-α inhibitor in non-infectious uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Dan Liang | Conditions: Uveitis, Adalimumab | Phase 2 | Status: UNKNOWN